ASX - Delayed Quote AUD

Argent BioPharma Limited (RGT.AX)

Compare
0.1400
-0.0200
(-12.50%)
At close: 3:14:18 PM GMT+11
All numbers in thousands
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-14,261.6110
-14,261.6110
-11,994.6380
-12,158.2260
-11,989.6120
Investing Cash Flow
-140.1230
-140.1230
606.1950
-1,111.1770
-1,493.7790
Financing Cash Flow
14,865.4410
14,865.4410
9,732.4540
9,737.8060
17,051.0580
End Cash Position
702.8700
702.8700
239.8210
1,886.3470
5,433.2410
Income Tax Paid Supplemental Data
292.4460
--
--
--
--
Interest Paid Supplemental Data
3.0570
3.0570
257.4030
25.4530
7.3980
Capital Expenditure
-140.1230
-140.1230
-189.8710
-2,693.1000
-3,327.1050
Issuance of Capital Stock
15,700.8920
15,700.8920
3,086.8030
10,703.4510
12,759.6970
Issuance of Debt
--
--
6,948.1060
--
5,750.0000
Repayment of Debt
61.4240
--
216.3380
61.4240
--
Repurchase of Capital Stock
-596.7720
-596.7720
-317.8380
-764.0610
-1,202.6460
Free Cash Flow
-14,401.7340
-14,401.7340
-12,184.5090
-14,851.3260
-15,316.7170
6/30/2021 - 3/24/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers